1. Share Prices

  2. Genus PLC (GNS)

2,365.00p-30.00 (-1.05%)07 Nov 2025, 14:30
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Genus PLC Fundamentals

Company NameGenus PLCLast Updated2025-11-07
IndustryBiotechnologySectorHealthcare
Shares in Issue66.413 mMarket Cap£1.57 bn
PE Ratio82.87Dividend per Share£0.32
Dividend Yield1.34Dividend Cover0.90
EPS£0.29EPS Growth (%)0.00
PEG0DPS Growth (%)0
Debt Ratio0.2958Debt Equity Ratio0.5245
Asset Equity Ratio1.8887Cash Equity Ratio0.1008
Quick Ratio1.1980Current Ratio1.94
Price To Book Value3.2992ROCE0

Genus PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Prelim2025-11-062025-12-05GBP0.2170
Interim2025-03-062025-04-04GBP0.1030
Prelim2024-11-072024-12-06GBP0.2170
Interim2024-02-292024-03-28GBP0.1030
Prelim2023-11-092023-12-08GBP0.2170
Interim2023-03-022023-03-30GBP0.1030
Prelim2022-11-172022-12-09GBP0.2170

Genus PLC Company Financials

Assets2025202420232022
Tangible Assets£160.30 m£182.00 m£164.40 m£171.40 m
Intangible Assets£158.10 m£175.70 m£174.00 m£183.00 m
Investments£66.00 m£61.60 m£62.30 m£51.40 m
Total Fixed Assets£644.60 m£716.70 m£707.40 m£760.40 m
Stocks£80.90 m£89.40 m£85.10 m£84.00 m
Debtors£109.30 m£122.50 m£132.10 m£119.40 m
Cash & Equivalents£48.00 m£42.50 m£36.30 m£38.80 m
Other Assets£260.20 m£297.40 m£306.70 m£354.60 m
Total Assets£899.00 m£987.80 m£966.40 m£1.02 bn
Liabilities2025202420232022
Creditors within 1 year£131.30 m£150.60 m£147.20 m£151.30 m
Creditors after 1 year£291.70 m£323.70 m£282.40 m£294.50 m
Other Liabilities0000
Total Liabilities£423.00 m£474.30 m£429.60 m£445.80 m
Net assets£476.00 m£513.50 m£536.80 m£572.10 m
Equity2025202420232022
Called up share capital£6.60 m£6.60 m£6.60 m£6.60 m
Share Premium£179.10 m£179.10 m£179.10 m£179.10 m
Profit / Loss£28.50 m£5.50 m£39.40 m£48.40 m
Other Equity£476.10 m£517.80 m£544.50 m£578.50 m
Preference & Minorities-£100,000.00-£4.30 m-£7.70 m-£6.40 m
Total Capital Employed£476.00 m£513.50 m£536.80 m£572.10 m
Ratios2025202420232022
Debt Ratio£0.34£0.34£0.29£0.26
Debt-to-Equity£0.52£0.53£0.40£0.36
Assets / Equity1.88871.88871.88871.8887
Cash / Equity0.10080.10080.10080.1008
EPS£0.40£0.40£0.55£0.65
Cash Flow2025202420232022
Cash from operating activities£67.20 m£29.80 m£50.40 m£34.30 m
Cashflow before financing£20.60 m£27.00 m£32.20 m£56.20 m
Increase in Cash£6.80 m£7.70 m£1.30 m-£11.00 m
Income2025202420232022
Turnover£672.80 m£668.80 m£689.70 m£593.40 m
Cost of sales£468.40 m£490.10 m£502.20 m£445.50 m
Gross Profit£204.40 m£178.70 m£187.50 m£147.90 m
Operating Profit£42.40 m£6.40 m£40.50 m£49.40 m
Pre-Tax profit£28.50 m£5.50 m£39.40 m£48.40 m

Genus PLC Company Background

SectorHealthcare
ActivitiesGenus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research anddevelopment.
Latest Interim Date27 Feb 2025
Latest Fiscal Year End Date4 Sep 2025

Genus PLC Directors

AppointedNamePosition
2023-09-30Mr. Stephen David WilsonExecutive Director
2014-11-14Professor Barry Furr, OBENon-Executive Director
2018-11-15Mr. Philip Noel Nigel TurnerNon-Executive Director
2011-10-12Mr. Richard Kenneth WoodExecutive Director,Chief Executive Officer
2022-10-14Mr. Robert Arthur Lawson Non-Executive Director,Chairman
2016-11-21Mr. Michael Charles BuzzacottNon-Executive Director
2025-10-10Ms. Lesley Mary Samuel Knox OBENon-Executive Director,Senior Independent Director; Workforce Engagement Director
2014-10-08Mr. John Graham WorbyExecutive Director,Finance Director
2025-10-10Mr. Iain George Thomas Ferguson CBENon-Executive Director,Chairman
2011-08-09Mr. David Peter TimminsExecutive Director,Finance Director
2009-05-18Mr. John Eric HawkinsNon-Executive Director,Chairman
2013-10-10Mr. Ian Brian FarrellyCompany Secretary
2025-10-10Mr. Daniel William David HartleyGroup General Counsel & Company Secretary
2007-11-01Ms. Edwin William WhiteNon-Executive Director
2011-08-09Mr. Martin Brett BodenExecutive Director,Group Finance Director
2020-10-16Mr. Karim BitarExecutive Director,Chief Executive Officer
2025-09-25Mr. Jorgen KokkeExecutive Director,Chief Executive Officer
2023-11-22Mr. Lykele van der BroekNon-Executive Director,Work Force Engagement Director
2025-07-31Ms. Alison Jane HenriksenExecutive Director,Chief Financial Officer
2025-09-11Mr. Andy RussellExecutive Director,Chief Financial Officer

Genus PLC Contact Details

Company NameGenus PLC
AddressMatrix House, Basing View, Basingstoke, RG21 4DZ
Telephone+44 1256347100
Websitehttps://www.genusplc.com

Genus PLC Advisors

SolicitorHerbert Smith Freehills LLP
Phone+44 2073748000
Fax+44 2073740888
Auditor Deloitte LLP
Phone+44 1189508141
Fax+44 1189508101
Remuneration ConsultantPricewaterhouseCoopers LLP
Phone+44 205835000
Fax+44 208224652
Financial AdviserHSBC Bank PLC
Phone(020) 7991 8888
Fax(020) 7991 4459
Financial Adviser HSBC Bank PLC
Phone+44 2079918888
Fax+44 2079914459
RegistrarEquiniti Limited
StockbrokerPeel Hunt LLP
Phone+44 2074188900
Fax+44 2074188848
Financial PR AdviserBuchanan
Phone+44 2074665000
Fax+44 2074665001
StockbrokerLiberum Capital Limited
Phone+44 2031002000
Fax+44 2031002299
BankBarclays Bank PLC

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
25 Sep 2025

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Itv PLC78.9517.40
Jtc PLC1,358.004.62
Oxford Nanopore Technologies PLC140.004.87
Hikma Pharmaceuticals PLC1,582.000.00
Coca-Cola Europacific Partners PLC6,950.001.76
Wpp PLC279.103.79
Risers/fallers data from previous trading day.